Men1611 is a PI3K α/β selective and δ sparing inhibitor with long-lasting antitumor activity in different genetic backgrounds of PIK3CA mutant breast cancer models Meeting Abstract


Authors: Fiascarelli, A.; Carrisi, C.; Merlino, G.; Capano, S.; Bisignano, D.; Talucci, S.; Bressan, A.; Bellarosa, D.; Bigioni, M.; Scaltriti, M.; Arribas, J.; Pellacani, A.; Salerno, M.; Binaschi, M.
Abstract Title: Men1611 is a PI3K α/β selective and δ sparing inhibitor with long-lasting antitumor activity in different genetic backgrounds of PIK3CA mutant breast cancer models
Meeting Title: 43rd Annual San Antonio Breast Cancer Symposium (2020 SABCS)
Journal Title: Cancer Research
Volume: 81
Issue: 4 Suppl.
Meeting Dates: 2020 Dec 8-11
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2021-02-01
Language: English
ACCESSION: WOS:000618737700634
PROVIDER: wos
DOI: 10.1158/1538-7445.SABCS20-PS18-13
Notes: Meeting Abstract: PS18-13 -- This symposium was held virtually due to COVID-19 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maurizio Scaltriti
    170 Scaltriti